Biotech

All Articles

Amgen files first period 3 gain for $400M dermatitis drug

.Amgen has actually shared (PDF) the initial phase 3 data on its own $400 thousand dermatitis medica...

Biogen, UCB document period 3 lupus win after failing earlier test

.Biogen and also UCB's gamble on developing into stage 3 astride a failed research study seeks to ha...

Aptadir hopes brand-new RNA inhibitors can easily turn around complicated cancers cells

.Italian biotech Aptadir Therapies has introduced with the pledge that its own pipeline of preclinic...

Wave surfs DMD excellence to regulators' doors, sending stock up

.Wave Lifestyle Sciences has actually met its goal in a Duchenne muscular dystrophy (DMD) research s...

Sanofi picks new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma cre...

Achilles droplets tissue treatment course, supports for cutbacks after missing 'industrial viability' goals

.Achilles Therapies has shreded its own method. The British biotech is stopping work on its clinical...

Aligos heralds period 2 MASH succeed, reducing liver excess fat around 46%

.Aligos Therapeutics is actually proclaiming a midstage win in metabolic-dysfunction affiliated stea...

Basilea ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's job building brand-new antifungals has actually gotten a significant increa...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Having already scooped up the united state civil rights to Capricor Rehabs' late-stage Duchenne mus...

FDA scraps adcomm for Applied's uncommon ailment medication

.After pushing the decision meeting for Applied Therapies' metabolic problem medicine govorestat, th...